0002090779-25-000001.txt : 20251008 0002090779-25-000001.hdr.sgml : 20251008 20251008154838 ACCESSION NUMBER: 0002090779-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251008 DATE AS OF CHANGE: 20251008 EFFECTIVENESS DATE: 20251008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rinascera Therapeutics, Inc. CENTRAL INDEX KEY: 0002090779 ORGANIZATION NAME: EIN: 393692053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560207 FILM NUMBER: 251382288 BUSINESS ADDRESS: STREET 1: 75 KNEELAND ST FL 14 CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: (408) 396-3123 MAIL ADDRESS: STREET 1: 75 KNEELAND ST FL 14 CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0002090779 Rinascera Therapeutics, Inc. 75 KNEELAND ST FL 14 BOSTON MA MASSACHUSETTS 02111 (408) 396-3123 DELAWARE None None Corporation true 2025 Nichola Eliovits 75 KNEELAND ST FL 14 BOSTON MA MASSACHUSETTS 02111 Executive Officer Director Max Dawson 75 KNEELAND ST FL 14 BOSTON MA MASSACHUSETTS 02111 Executive Officer Karl Beutner 75 KNEELAND ST FL 14 BOSTON MA MASSACHUSETTS 02111 Executive Officer Director Daniel Yadegar 75 KNEELAND ST FL 14 BOSTON MA MASSACHUSETTS 02111 Director Biotechnology Decline to Disclose 06b false 2025-09-12 false true false 0 2500000 2500000 0 false 3 0 0 0 false Rinascera Therapeutics, Inc. /s/ Nichola Eliovits Nichola Eliovits Chief Executive Officer 2025-10-08